Placebo News and Research

RSS

Psoriasis trial enters final stage

Solbec Pharmaceuticals Ltd today announced the successful completion of the first two stages of the Phase I clinical trial of its lead compound, CoramsineTM (SBP002), for the treatment of psoriasis.

4 Nov 2004

High-dose statin therapy for aggressive cholesterol-lowering outperforms typical care

Patients treated with high doses of atorvastatin had about a one percent lower annual rate of heart attacks than similar patients receiving usual care, according to a new study in the Nov. 2, 2004 issue of the Journal of the American College of Cardiology.

2 Nov 2004

Reproductive hormones have effects on all of these stages of brain growth and development

Scientists are now uncovering increasing evidence that the brain not only responds to hormones produced by the reproductive system, but that these hormones-the so-called "female hormones," estrogen and progestin, and the "male" androgens, such as testosterone-play an important role in the development of differences between male and female brains.

2 Nov 2004

Researcher finds no long-term benefit of using glucosamine for knee joint pain

A popular food supplement used to treat osteoarthritis pain in knee joints has been shown to have no long-term beneficial effect, according to a national study conducted by a University of British Columbia post-doctoral fellow working at the Arthritis Research Centre of Canada

1 Nov 2004

Do cholesterol-reducing drugs decrease the risk of heart attacks and strokes in diabetics?

International researchers will, for the first time, present findings from the landmark 4D trial about whether a cholesterol-reducing drug decreases the risk of heart attacks and strokes with type 2 diabetics on dialysis at the American Society of Nephrology’s 37th Annual Meeting and Scientific Exposition in St. Louis, Missouri.

1 Nov 2004

Gel significantly increases sexual activity in surgically menopausal women

BioSante Pharmaceuticals today announced the presentation of new Phase II clinical data on LibiGel™ (transdermal testosterone gel) at the International Society for the Study of Women's Sexual Health (ISSWSH) Annual Meeting in Atlanta.

1 Nov 2004

New therapy under development for the treatment of irritable bowel syndrome

A new therapy under development for the treatment of irritable bowel syndrome with diarrhea predominance appears to provide significant improvements in measures of quality of life, according to a study presented at the 69th Annual Meeting of the American College of Gastroenterology.

1 Nov 2004

Long-term medication and counseling helps smokers quit

People who want to quit smoking have an improved chance of success if they receive long-term comprehensive drug and psychological interventions, according to a new study by UCSF researchers.

1 Nov 2004

Practical lifestyle tips that can ease living with prostate problems

Symptoms of an enlarged prostate — known medically as benign prostatic hyperplasia (BPH) — can range from a weak, slow urinary stream, to hesitancy and straining to urinate, to an inability to empty the bladder completely, to more serious complications including recurrent urinary tract infections and kidney damage.

29 Oct 2004

New insights into hormone therapy show when estrogen best aids brain

New hormone therapy studies demonstrate estrogen's ability to directly stimulate neurons, repair damaged neurons, and stimulate support cells—most of which can alleviate some of the cognitive decline associated with menopause.

28 Oct 2004

Marijuana-like compounds may aid Parkinson's disease, pain and obesity

No longer a pipe dream, new animal research now indicates that marijuana-like compounds can aid a bevy of debilitating conditions, ranging from brain disorders such as amyotrophic lateral sclerosis (ALS) and Parkinson's disease, to pain and obesity.

28 Oct 2004

Ruboxistaurin may reduce vision loss from diabetes-induced eye disease

Eli Lilly and Company's investigational compound ruboxistaurin may reduce vision loss from diabetes-induced eye disease, according to new analyses of previously reported data presented at the 2004 Joint Meeting of the American Academy of Ophthalmology and the European Society of Ophthalmology in New Orleans, La.

26 Oct 2004

Genes affect how asthma patients respond to albuterol

While a few weeks of regular use of albuterol improved overall asthma control in individuals with one form of the gene, stopping all use of albuterol eventually improved asthma control in those with another form of the gene. Albuterol is the most commonly used drug for relief of acute asthma symptoms, or “attacks.”

22 Oct 2004

MedImmune initiates clinical trial comparing intranasal influenza vaccine with injectable flu vaccine

MedImmune announced that it has initiated a pivotal head-to-head Phase 3 clinical trial designed to compare its next-generation, refrigerator- stable intranasal influenza vaccine (CAIV-T: cold adapted intranasal influenza vaccine, trivalent) with the injectable flu shot (TIV: trivalent influenza vaccine).

22 Oct 2004

Highly sensitive receptors in the brain may function differently in a person with a family history of alcoholism

Receptors in the brain that are highly sensitive to alcohol may function differently in a person with a family history of alcoholism, according to a Yale study published this month.

21 Oct 2004

Evidence showing treatment benefits of beta interferon for multiple sclerosis

Results of a European study in this week’s issue of THE LANCET provide further evidence that patients with early symptoms of multiple sclerosis given a weekly injection with interferon beta are less likely to progress to full clinical disease after two years follow-up.

21 Oct 2004

Leading endocrinologist supports RMIT menopause research

Leading endocrinologist Dr Helena Teede has joined the research team of an RMIT University study that might shed light on the treatment of menopausal symptoms using herbal medicines.

21 Oct 2004

Patients with stable vitiligo may achieve good repigmentation with skin transplants using skin taken from normally-pigmented areas of their own bodies

Patients with stable vitiligo, a skin disorder characterized by patches of lighter colored, or depigmented skin, may achieve good repigmentation of these areas with skin transplants using skin taken from normally-pigmented areas of their own bodies

18 Oct 2004

Cymbalta significantly reduced pain in more than half of women treated for fibromyalgia, with and without major depression

The antidepressant Cymbalta (duloxetine HCl), a dual-reuptake inhibitor of serotonin and norepinephrine, 60 mg once or twice daily, significantly reduced pain in more than half of women treated for fibromyalgia, with and without major depression, according to 12-week data presented at the annual meeting of the American College of Rheumatology.

18 Oct 2004

FDA issues warning on adolescent use of antidepressants

The Food and Drug Administration (FDA) has issued a Public Health Advisory announcing a multi-pronged strategy to warn the public about the increased risk of suicidal thoughts and behavior ("suicidality") in children and adolescents being treated with antidepressant medications.

18 Oct 2004

Placebo News and Research

Psoriasis trial enters final stage

High-dose statin therapy for aggressive cholesterol-lowering outperforms typical care

Reproductive hormones have effects on all of these stages of brain growth and development

Researcher finds no long-term benefit of using glucosamine for knee joint pain

Do cholesterol-reducing drugs decrease the risk of heart attacks and strokes in diabetics?

Gel significantly increases sexual activity in surgically menopausal women

New therapy under development for the treatment of irritable bowel syndrome

Long-term medication and counseling helps smokers quit

Practical lifestyle tips that can ease living with prostate problems

New insights into hormone therapy show when estrogen best aids brain

Marijuana-like compounds may aid Parkinson's disease, pain and obesity

Ruboxistaurin may reduce vision loss from diabetes-induced eye disease

Genes affect how asthma patients respond to albuterol

MedImmune initiates clinical trial comparing intranasal influenza vaccine with injectable flu vaccine

Highly sensitive receptors in the brain may function differently in a person with a family history of alcoholism

Evidence showing treatment benefits of beta interferon for multiple sclerosis

Leading endocrinologist supports RMIT menopause research

Patients with stable vitiligo may achieve good repigmentation with skin transplants using skin taken from normally-pigmented areas of their own bodies

Cymbalta significantly reduced pain in more than half of women treated for fibromyalgia, with and without major depression

FDA issues warning on adolescent use of antidepressants

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News